Global Biosimilars-On-Biologics Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

Publisher Name :
Date: 17-Dec-2020
No. of pages: 127

Based on the Biosimilars-On-Biologics market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.

In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.

In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Biosimilars-On-Biologics market covered in Chapter 5:

Hospira

Biocon

Biogen idec Inc.

Synthon Pharmaceuticals, Inc.

Merck Serono

Celltrion

Teva Pharmaceutical Industries Ltd.

LG Life Sciences

Novartis

In Chapter 6, on the basis of types, the Biosimilars-On-Biologics market from 2015 to 2025 is primarily split into:

Human growth hormone

Erythropoietin

Monoclonal antibodies

Insulin

Interferon

Granulocyte-Colony Stimulating Factor

Peptide

In Chapter 7, on the basis of applications, the Biosimilars-On-Biologics market from 2015 to 2025 covers:

Blood disorders

Oncology diseases

Chronic and autoimmune diseases

Growth hormone deficiencies

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:

North America (Covered in Chapter 9)

United States

Canada

Mexico

Europe (Covered in Chapter 10)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 11)

China

Japan

South Korea

Australia

India

South America (Covered in Chapter 12)

Brazil

Argentina

Columbia

Middle East and Africa (Covered in Chapter 13)

UAE

Egypt

South Africa

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Global Biosimilars-On-Biologics Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Biosimilars-On-Biologics Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact

3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies
5.1 Hospira
5.1.1 Hospira Company Profile
5.1.2 Hospira Business Overview
5.1.3 Hospira Biosimilars-On-Biologics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Hospira Biosimilars-On-Biologics Products Introduction
5.2 Biocon
5.2.1 Biocon Company Profile
5.2.2 Biocon Business Overview
5.2.3 Biocon Biosimilars-On-Biologics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Biocon Biosimilars-On-Biologics Products Introduction
5.3 Biogen idec Inc.
5.3.1 Biogen idec Inc. Company Profile
5.3.2 Biogen idec Inc. Business Overview
5.3.3 Biogen idec Inc. Biosimilars-On-Biologics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Biogen idec Inc. Biosimilars-On-Biologics Products Introduction
5.4 Synthon Pharmaceuticals, Inc.
5.4.1 Synthon Pharmaceuticals, Inc. Company Profile
5.4.2 Synthon Pharmaceuticals, Inc. Business Overview
5.4.3 Synthon Pharmaceuticals, Inc. Biosimilars-On-Biologics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Synthon Pharmaceuticals, Inc. Biosimilars-On-Biologics Products Introduction
5.5 Merck Serono
5.5.1 Merck Serono Company Profile
5.5.2 Merck Serono Business Overview
5.5.3 Merck Serono Biosimilars-On-Biologics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Merck Serono Biosimilars-On-Biologics Products Introduction
5.6 Celltrion
5.6.1 Celltrion Company Profile
5.6.2 Celltrion Business Overview
5.6.3 Celltrion Biosimilars-On-Biologics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Celltrion Biosimilars-On-Biologics Products Introduction
5.7 Teva Pharmaceutical Industries Ltd.
5.7.1 Teva Pharmaceutical Industries Ltd. Company Profile
5.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
5.7.3 Teva Pharmaceutical Industries Ltd. Biosimilars-On-Biologics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Teva Pharmaceutical Industries Ltd. Biosimilars-On-Biologics Products Introduction
5.8 LG Life Sciences
5.8.1 LG Life Sciences Company Profile
5.8.2 LG Life Sciences Business Overview
5.8.3 LG Life Sciences Biosimilars-On-Biologics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 LG Life Sciences Biosimilars-On-Biologics Products Introduction
5.9 Novartis
5.9.1 Novartis Company Profile
5.9.2 Novartis Business Overview
5.9.3 Novartis Biosimilars-On-Biologics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Novartis Biosimilars-On-Biologics Products Introduction

6 Market Analysis and Forecast, By Product Types
6.1 Global Biosimilars-On-Biologics Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Biosimilars-On-Biologics Sales and Market Share by Types (2015-2020)
6.1.2 Global Biosimilars-On-Biologics Revenue and Market Share by Types (2015-2020)
6.1.3 Global Biosimilars-On-Biologics Price by Types (2015-2020)
6.2 Global Biosimilars-On-Biologics Market Forecast by Types (2020-2025)
6.2.1 Global Biosimilars-On-Biologics Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Biosimilars-On-Biologics Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Biosimilars-On-Biologics Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Biosimilars-On-Biologics Sales, Price and Growth Rate of Human growth hormone
6.3.2 Global Biosimilars-On-Biologics Sales, Price and Growth Rate of Erythropoietin
6.3.3 Global Biosimilars-On-Biologics Sales, Price and Growth Rate of Monoclonal antibodies
6.3.4 Global Biosimilars-On-Biologics Sales, Price and Growth Rate of Insulin
6.3.5 Global Biosimilars-On-Biologics Sales, Price and Growth Rate of Interferon
6.3.6 Global Biosimilars-On-Biologics Sales, Price and Growth Rate of Granulocyte-Colony Stimulating Factor
6.3.7 Global Biosimilars-On-Biologics Sales, Price and Growth Rate of Peptide
6.4 Global Biosimilars-On-Biologics Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Human growth hormone Market Revenue and Sales Forecast (2020-2025)
6.4.2 Erythropoietin Market Revenue and Sales Forecast (2020-2025)
6.4.3 Monoclonal antibodies Market Revenue and Sales Forecast (2020-2025)
6.4.4 Insulin Market Revenue and Sales Forecast (2020-2025)
6.4.5 Interferon Market Revenue and Sales Forecast (2020-2025)
6.4.6 Granulocyte-Colony Stimulating Factor Market Revenue and Sales Forecast (2020-2025)
6.4.7 Peptide Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications
7.1 Global Biosimilars-On-Biologics Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Biosimilars-On-Biologics Sales and Market Share by Applications (2015-2020)
7.1.2 Global Biosimilars-On-Biologics Revenue and Market Share by Applications (2015-2020)
7.2 Global Biosimilars-On-Biologics Market Forecast by Applications (2020-2025)
7.2.1 Global Biosimilars-On-Biologics Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Biosimilars-On-Biologics Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Biosimilars-On-Biologics Revenue, Sales and Growth Rate of Blood disorders (2015-2020)
7.3.2 Global Biosimilars-On-Biologics Revenue, Sales and Growth Rate of Oncology diseases (2015-2020)
7.3.3 Global Biosimilars-On-Biologics Revenue, Sales and Growth Rate of Chronic and autoimmune diseases (2015-2020)
7.3.4 Global Biosimilars-On-Biologics Revenue, Sales and Growth Rate of Growth hormone deficiencies (2015-2020)
7.4 Global Biosimilars-On-Biologics Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Blood disorders Market Revenue and Sales Forecast (2020-2025)
7.4.2 Oncology diseases Market Revenue and Sales Forecast (2020-2025)
7.4.3 Chronic and autoimmune diseases Market Revenue and Sales Forecast (2020-2025)
7.4.4 Growth hormone deficiencies Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions
8.1 Global Biosimilars-On-Biologics Sales by Regions (2015-2020)
8.2 Global Biosimilars-On-Biologics Market Revenue by Regions (2015-2020)
8.3 Global Biosimilars-On-Biologics Market Forecast by Regions (2020-2025)

9 North America Biosimilars-On-Biologics Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
9.3 North America Biosimilars-On-Biologics Market Revenue and Growth Rate (2015-2020)
9.4 North America Biosimilars-On-Biologics Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Biosimilars-On-Biologics Market Analysis by Country
9.6.1 U.S. Biosimilars-On-Biologics Sales and Growth Rate
9.6.2 Canada Biosimilars-On-Biologics Sales and Growth Rate
9.6.3 Mexico Biosimilars-On-Biologics Sales and Growth Rate

10 Europe Biosimilars-On-Biologics Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
10.3 Europe Biosimilars-On-Biologics Market Revenue and Growth Rate (2015-2020)
10.4 Europe Biosimilars-On-Biologics Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Biosimilars-On-Biologics Market Analysis by Country
10.6.1 Germany Biosimilars-On-Biologics Sales and Growth Rate
10.6.2 United Kingdom Biosimilars-On-Biologics Sales and Growth Rate
10.6.3 France Biosimilars-On-Biologics Sales and Growth Rate
10.6.4 Italy Biosimilars-On-Biologics Sales and Growth Rate
10.6.5 Spain Biosimilars-On-Biologics Sales and Growth Rate
10.6.6 Russia Biosimilars-On-Biologics Sales and Growth Rate

11 Asia-Pacific Biosimilars-On-Biologics Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Biosimilars-On-Biologics Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Biosimilars-On-Biologics Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Biosimilars-On-Biologics Market Analysis by Country
11.6.1 China Biosimilars-On-Biologics Sales and Growth Rate
11.6.2 Japan Biosimilars-On-Biologics Sales and Growth Rate
11.6.3 South Korea Biosimilars-On-Biologics Sales and Growth Rate
11.6.4 Australia Biosimilars-On-Biologics Sales and Growth Rate
11.6.5 India Biosimilars-On-Biologics Sales and Growth Rate

12 South America Biosimilars-On-Biologics Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
12.3 South America Biosimilars-On-Biologics Market Revenue and Growth Rate (2015-2020)
12.4 South America Biosimilars-On-Biologics Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Biosimilars-On-Biologics Market Analysis by Country
12.6.1 Brazil Biosimilars-On-Biologics Sales and Growth Rate
12.6.2 Argentina Biosimilars-On-Biologics Sales and Growth Rate
12.6.3 Columbia Biosimilars-On-Biologics Sales and Growth Rate

13 Middle East and Africa Biosimilars-On-Biologics Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Biosimilars-On-Biologics Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Biosimilars-On-Biologics Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Biosimilars-On-Biologics Market Analysis by Country
13.6.1 UAE Biosimilars-On-Biologics Sales and Growth Rate
13.6.2 Egypt Biosimilars-On-Biologics Sales and Growth Rate
13.6.3 South Africa Biosimilars-On-Biologics Sales and Growth Rate

14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 Appendix
15.1 Methodology
15.2 Research Data Source

List of Tables and Figures

Figure Product Picture
Figure Global Biosimilars-On-Biologics Market Size and Growth Rate 2015-2025
Table Biosimilars-On-Biologics Key Market Segments
Figure Global Biosimilars-On-Biologics Market Revenue ($) Segment by Type from 2015-2020
Figure Global Biosimilars-On-Biologics Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Biosimilars-On-Biologics
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Hospira Company Profile
Table Hospira Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Hospira Production and Growth Rate
Figure Hospira Market Revenue ($) Market Share 2015-2020
Table Biocon Company Profile
Table Biocon Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Biocon Production and Growth Rate
Figure Biocon Market Revenue ($) Market Share 2015-2020
Table Biogen idec Inc. Company Profile
Table Biogen idec Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Biogen idec Inc. Production and Growth Rate
Figure Biogen idec Inc. Market Revenue ($) Market Share 2015-2020
Table Synthon Pharmaceuticals, Inc. Company Profile
Table Synthon Pharmaceuticals, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Synthon Pharmaceuticals, Inc. Production and Growth Rate
Figure Synthon Pharmaceuticals, Inc. Market Revenue ($) Market Share 2015-2020
Table Merck Serono Company Profile
Table Merck Serono Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Merck Serono Production and Growth Rate
Figure Merck Serono Market Revenue ($) Market Share 2015-2020
Table Celltrion Company Profile
Table Celltrion Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Celltrion Production and Growth Rate
Figure Celltrion Market Revenue ($) Market Share 2015-2020
Table Teva Pharmaceutical Industries Ltd. Company Profile
Table Teva Pharmaceutical Industries Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Market Revenue ($) Market Share 2015-2020
Table LG Life Sciences Company Profile
Table LG Life Sciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure LG Life Sciences Production and Growth Rate
Figure LG Life Sciences Market Revenue ($) Market Share 2015-2020
Table Novartis Company Profile
Table Novartis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novartis Production and Growth Rate
Figure Novartis Market Revenue ($) Market Share 2015-2020
Table Global Biosimilars-On-Biologics Sales by Types (2015-2020)
Table Global Biosimilars-On-Biologics Sales Share by Types (2015-2020)
Table Global Biosimilars-On-Biologics Revenue ($) by Types (2015-2020)
Table Global Biosimilars-On-Biologics Revenue Share by Types (2015-2020)
Table Global Biosimilars-On-Biologics Price ($) by Types (2015-2020)
Table Global Biosimilars-On-Biologics Market Forecast Sales by Types (2020-2025)
Table Global Biosimilars-On-Biologics Market Forecast Sales Share by Types (2020-2025)
Table Global Biosimilars-On-Biologics Market Forecast Revenue ($) by Types (2020-2025)
Table Global Biosimilars-On-Biologics Market Forecast Revenue Share by Types (2020-2025)
Figure Global Human growth hormone Sales and Growth Rate (2015-2020)
Figure Global Human growth hormone Price (2015-2020)
Figure Global Erythropoietin Sales and Growth Rate (2015-2020)
Figure Global Erythropoietin Price (2015-2020)
Figure Global Monoclonal antibodies Sales and Growth Rate (2015-2020)
Figure Global Monoclonal antibodies Price (2015-2020)
Figure Global Insulin Sales and Growth Rate (2015-2020)
Figure Global Insulin Price (2015-2020)
Figure Global Interferon Sales and Growth Rate (2015-2020)
Figure Global Interferon Price (2015-2020)
Figure Global Granulocyte-Colony Stimulating Factor Sales and Growth Rate (2015-2020)
Figure Global Granulocyte-Colony Stimulating Factor Price (2015-2020)
Figure Global Peptide Sales and Growth Rate (2015-2020)
Figure Global Peptide Price (2015-2020)
Figure Global Biosimilars-On-Biologics Market Revenue ($) and Growth Rate Forecast of Human growth hormone (2020-2025)
Figure Global Biosimilars-On-Biologics Sales and Growth Rate Forecast of Human growth hormone (2020-2025)
Figure Global Biosimilars-On-Biologics Market Revenue ($) and Growth Rate Forecast of Erythropoietin (2020-2025)
Figure Global Biosimilars-On-Biologics Sales and Growth Rate Forecast of Erythropoietin (2020-2025)
Figure Global Biosimilars-On-Biologics Market Revenue ($) and Growth Rate Forecast of Monoclonal antibodies (2020-2025)
Figure Global Biosimilars-On-Biologics Sales and Growth Rate Forecast of Monoclonal antibodies (2020-2025)
Figure Global Biosimilars-On-Biologics Market Revenue ($) and Growth Rate Forecast of Insulin (2020-2025)
Figure Global Biosimilars-On-Biologics Sales and Growth Rate Forecast of Insulin (2020-2025)
Figure Global Biosimilars-On-Biologics Market Revenue ($) and Growth Rate Forecast of Interferon (2020-2025)
Figure Global Biosimilars-On-Biologics Sales and Growth Rate Forecast of Interferon (2020-2025)
Figure Global Biosimilars-On-Biologics Market Revenue ($) and Growth Rate Forecast of Granulocyte-Colony Stimulating Factor (2020-2025)
Figure Global Biosimilars-On-Biologics Sales and Growth Rate Forecast of Granulocyte-Colony Stimulating Factor (2020-2025)
Figure Global Biosimilars-On-Biologics Market Revenue ($) and Growth Rate Forecast of Peptide (2020-2025)
Figure Global Biosimilars-On-Biologics Sales and Growth Rate Forecast of Peptide (2020-2025)
Table Global Biosimilars-On-Biologics Sales by Applications (2015-2020)
Table Global Biosimilars-On-Biologics Sales Share by Applications (2015-2020)
Table Global Biosimilars-On-Biologics Revenue ($) by Applications (2015-2020)
Table Global Biosimilars-On-Biologics Revenue Share by Applications (2015-2020)
Table Global Biosimilars-On-Biologics Market Forecast Sales by Applications (2020-2025)
Table Global Biosimilars-On-Biologics Market Forecast Sales Share by Applications (2020-2025)
Table Global Biosimilars-On-Biologics Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Biosimilars-On-Biologics Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Blood disorders Sales and Growth Rate (2015-2020)
Figure Global Blood disorders Price (2015-2020)
Figure Global Oncology diseases Sales and Growth Rate (2015-2020)
Figure Global Oncology diseases Price (2015-2020)
Figure Global Chronic and autoimmune diseases Sales and Growth Rate (2015-2020)
Figure Global Chronic and autoimmune diseases Price (2015-2020)
Figure Global Growth hormone deficiencies Sales and Growth Rate (2015-2020)
Figure Global Growth hormone deficiencies Price (2015-2020)
Figure Global Biosimilars-On-Biologics Market Revenue ($) and Growth Rate Forecast of Blood disorders (2020-2025)
Figure Global Biosimilars-On-Biologics Sales and Growth Rate Forecast of Blood disorders (2020-2025)
Figure Global Biosimilars-On-Biologics Market Revenue ($) and Growth Rate Forecast of Oncology diseases (2020-2025)
Figure Global Biosimilars-On-Biologics Sales and Growth Rate Forecast of Oncology diseases (2020-2025)
Figure Global Biosimilars-On-Biologics Market Revenue ($) and Growth Rate Forecast of Chronic and autoimmune diseases (2020-2025)
Figure Global Biosimilars-On-Biologics Sales and Growth Rate Forecast of Chronic and autoimmune diseases (2020-2025)
Figure Global Biosimilars-On-Biologics Market Revenue ($) and Growth Rate Forecast of Growth hormone deficiencies (2020-2025)
Figure Global Biosimilars-On-Biologics Sales and Growth Rate Forecast of Growth hormone deficiencies (2020-2025)
Figure Global Biosimilars-On-Biologics Sales and Growth Rate (2015-2020)
Table Global Biosimilars-On-Biologics Sales by Regions (2015-2020)
Table Global Biosimilars-On-Biologics Sales Market Share by Regions (2015-2020)
Figure Global Biosimilars-On-Biologics Sales Market Share by Regions in 2019
Figure Global Biosimilars-On-Biologics Revenue and Growth Rate (2015-2020)
Table Global Biosimilars-On-Biologics Revenue by Regions (2015-2020)
Table Global Biosimilars-On-Biologics Revenue Market Share by Regions (2015-2020)
Figure Global Biosimilars-On-Biologics Revenue Market Share by Regions in 2019
Table Global Biosimilars-On-Biologics Market Forecast Sales by Regions (2020-2025)
Table Global Biosimilars-On-Biologics Market Forecast Sales Share by Regions (2020-2025)
Table Global Biosimilars-On-Biologics Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Biosimilars-On-Biologics Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure North America Biosimilars-On-Biologics Market Revenue and Growth Rate (2015-2020)
Figure North America Biosimilars-On-Biologics Market Forecast Sales (2020-2025)
Figure North America Biosimilars-On-Biologics Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Canada Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Mexico Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Europe Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Europe Biosimilars-On-Biologics Market Revenue and Growth Rate (2015-2020)
Figure Europe Biosimilars-On-Biologics Market Forecast Sales (2020-2025)
Figure Europe Biosimilars-On-Biologics Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure France Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Italy Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Spain Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Russia Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biosimilars-On-Biologics Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Biosimilars-On-Biologics Market Forecast Sales (2020-2025)
Figure Asia-Pacific Biosimilars-On-Biologics Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Japan Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure South Korea Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Australia Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure India Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure South America Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure South America Biosimilars-On-Biologics Market Revenue and Growth Rate (2015-2020)
Figure South America Biosimilars-On-Biologics Market Forecast Sales (2020-2025)
Figure South America Biosimilars-On-Biologics Market Forecast Revenue ($) (2020-2025)
Figure Brazil Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Argentina Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Columbia Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biosimilars-On-Biologics Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Biosimilars-On-Biologics Market Forecast Sales (2020-2025)
Figure Middle East and Africa Biosimilars-On-Biologics Market Forecast Revenue ($) (2020-2025)
Figure UAE Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure Egypt Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
Figure South Africa Biosimilars-On-Biologics Market Sales and Growth Rate (2015-2020)
  • Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147
    According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
  • Global Biosimilar Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147
    According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
  • Global Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
  • Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs